du-21220 has been researched along with thromboxanes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekblad, U; Erkkola, R; Kanto, J; Palo, P; Uotila, P | 1 |
| Jouppila, P; Kirkinen, P; Koivula, A; Ylikorkala, O | 1 |
| Jouppila, P; Kirkinen, P; Viinikka, L; Ylikorkala, O | 1 |
1 trial(s) available for du-21220 and thromboxanes
| Article | Year |
|---|---|
Ritodrine infusion at term: effects on maternal and fetal prostacyclin, thromboxane and prostaglandin precursor fatty acids.
Topics: 6-Ketoprostaglandin F1 alpha; Epoprostenol; Fatty Acids; Female; Fetal Blood; Humans; Infant, Newborn; Phospholipids; Pregnancy; Prospective Studies; Random Allocation; Ritodrine; Thromboxanes | 1988 |
2 other study(ies) available for du-21220 and thromboxanes
| Article | Year |
|---|---|
Ritodrine infusion during late pregnancy: effects on fetal and placental blood flow, prostacyclin, and thromboxane.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Pressure; Epoprostenol; Female; Fetal Heart; Fetus; Heart Rate; Humans; Obstetric Labor, Premature; Placenta; Pregnancy; Propanolamines; Regional Blood Flow; Ritodrine; Thromboxane A2; Thromboxane B2; Thromboxanes; Umbilical Veins; Vascular Resistance | 1985 |
Maternal prostacyclin, thromboxane, and placental blood flow.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Infusions, Parenteral; Obstetric Labor, Premature; Placenta; Pregnancy; Pregnancy Complications; Prostaglandins; Regional Blood Flow; Ritodrine; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |